WALD Q4 2024 Earnings EPS Misses Estimates Significantly as Stock Rises GLPG Q1 2026 Earnings Large EPS Beat on Lower Costs Stock Unchanged VABK Q1 2026 Earnings Steady Profitability Amidst Negative Market Reaction Milestone Pharmaceuticals MIST Q1 2026 Earnings EPS Miss Deepens as ClinicalStage Biotech Navigates Development Path ZOOZ Q2 2025 Earnings EPS Misses Estimates Stock Rises 876 OPRA Q1 2026 Earnings EPS Surpasses Estimates Stock Declines Modestly